Amsterdam, Netherlands

Iwan Jozef Philomena De Esch

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Iwan Jozef Philomena De Esch: Innovations in Heterocyclic Compounds

Introduction

Iwan Jozef Philomena De Esch is a notable inventor based in Amsterdam, Netherlands. With a single patent to his name, he has made a significant contribution to the field of medicinal chemistry through his innovative work on quinazolines and related heterocyclic compounds.

Latest Patents

De Esch's patent focuses on "Quinazolines and related heterocyclic compounds, and their therapeutic use." The invention relates to a compound of the formula (I), where X and Y can be carbon or nitrogen, and various substituents like hydrogen, halogens, or hydrocarbon groups may be included. The compounds also feature a heterocyclic group with nitrogen atoms, allowing for the creation of a diversity of molecules aimed at therapeutic applications. Additionally, the patent covers pharmaceutically acceptable salts, esters, or solvates of these compounds.

Career Highlights

Iwan Jozef Philomena De Esch is affiliated with the Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg, where he engages in research and development. His work emphasizes the importance of scientific research in healthcare and the development of new therapeutic compounds.

Collaborations

Throughout his career, De Esch has collaborated with professionals such as Rogier Adriaan Smits and Regorius Leurs. These partnerships have contributed to advancements in their respective fields and have fostered a collaborative research environment that encourages innovative solutions in patient care and medical research.

Conclusion

Iwan Jozef Philomena De Esch stands out as an influential inventor whose work on quinazolines contributes to the vast landscape of medicinal inventions. His collaboration with dedicated professionals and his commitment to advancing therapeutic compounds have the potential to transform healthcare practices, making him a notable figure in the realm of innovation in the Netherlands.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…